| Company Name |
Market Cap |
TEV |
TEV/LTM Total Rev |
TEV/LTM EBITDA |
TEV/LTM EBIT |
P/Diluted EPS Before Extra |
P/TangBV |
| 3M Co. |
54,915 |
57,754 |
2x |
9x |
11x |
14x |
9x |
| Abbott Laboratories |
85,958 |
95,351 |
4x |
15x |
20x |
24x |
- |
| Alcon Inc. |
41,655 |
40,655 |
7x |
19x |
21x |
27x |
16x |
| Amgen Inc. |
43,494 |
47,520 |
3x |
7x |
9x |
14x |
13x |
| B. Braun Melsungen AG |
0 |
0 |
- |
- |
- |
- |
- |
| Baxter International Inc. |
36,385 |
36,935 |
3x |
13x |
16x |
22x |
8x |
| Bayer AG |
37,835 |
49,833 |
2x |
8x |
14x |
16x |
- |
| Becton, Dickinson and Company |
21,504 |
21,750 |
3x |
12x |
16x |
23x |
6x |
| Boston Scientific Corp. |
18,490 |
25,227 |
3x |
12x |
20x |
- |
- |
| Cardinal Health Inc. |
18,753 |
21,639 |
x |
9x |
10x |
23x |
15x |
| Covidien, Ltd. |
21,312 |
24,278 |
2x |
10x |
12x |
- |
- |
| CR Bard Inc. |
9,965 |
9,553 |
4x |
15x |
17x |
26x |
9x |
| Edwards Lifesciences Corp. |
2,579 |
2,600 |
2x |
11x |
15x |
24x |
7x |
| Hospira Inc. |
6,800 |
8,802 |
3x |
12x |
17x |
50x |
- |
| Johnson & Johnson |
184,473 |
184,695 |
3x |
10x |
12x |
18x |
13x |
| Medtronic Inc. |
54,366 |
60,033 |
5x |
13x |
16x |
25x |
46x |
| Olympus Corp. |
762,169 |
1,058,645 |
1x |
7x |
9x |
13x |
3x |
| Siemens Medical Solutions Diagnostics Ltd |
1,175 |
769 |
1x |
3x |
3x |
4x |
3x |
| Smith & Nephew plc |
5,481 |
6,789 |
2x |
9x |
14x |
18x |
34x |
| St. Jude Medical Inc. |
14,630 |
15,597 |
4x |
14x |
17x |
27x |
19x |
| Steris Corp. |
1,666 |
1,744 |
1x |
9x |
13x |
22x |
4x |
| Stryker Corp. |
26,229 |
23,835 |
4x |
14x |
18x |
27x |
6x |
| Terumo Corp. |
1,008,894 |
959,506 |
3x |
12x |
15x |
24x |
4x |
| |
|
High |
7x |
19x |
21x |
50x |
46x |
| |
|
Low |
x |
3x |
3x |
4x |
3x |
| |
|
Mean |
3x |
11x |
14x |
22x |
13x |
| |
|
Median |
3x |
12x |
15x |
23x |
9x |
